ASIA VITAL COMPONENTS CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 620 TWD | -6.06% |
|
-15.76% | +84.25% |
| May. 10 | Asia Vital Components Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Mar. 18 | Asia Vital Components Co., Ltd.(TWSE:3017) added to FTSE All-World Index | CI |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 14,715 | 23,354 | 31,162 | 39,571 | 128,984 | 256,818 | - | - |
| Enterprise Value (EV) 1 | 14,715 | 18,995 | 26,976 | 30,814 | 114,987 | 237,573 | 229,664 | 222,604 |
| P/E ratio | - | - | - | - | 23.8 x | 31.8 x | 22.3 x | 19 x |
| Yield | - | 4.24% | 3.74% | 4.04% | 2.08% | 1.44% | 2.11% | 2.57% |
| Capitalization / Revenue | 0.4 x | 0.59 x | 0.66 x | 0.71 x | 2.18 x | 3.59 x | 2.72 x | 2.32 x |
| EV / Revenue | 0.4 x | 0.48 x | 0.57 x | 0.55 x | 1.94 x | 3.32 x | 2.43 x | 2.01 x |
| EV / EBITDA | - | 4.22 x | 4.21 x | 3.84 x | 12.3 x | 18.2 x | 11.8 x | 9.43 x |
| EV / FCF | - | 7.72 x | 20.7 x | 5.92 x | 17.2 x | 32.6 x | 20.6 x | 18.8 x |
| FCF Yield | - | 13% | 4.82% | 16.9% | 5.8% | 3.07% | 4.86% | 5.31% |
| Price to Book | - | 2.21 x | 2.51 x | 2.55 x | 5.86 x | 8.52 x | 6.77 x | 5.37 x |
| Nbr of stocks (in thousands) | 353,310 | 353,310 | 353,310 | 353,310 | 383,310 | 383,310 | - | - |
| Reference price 2 | 41.65 | 66.10 | 88.20 | 112.0 | 336.5 | 620.0 | 620.0 | 620.0 |
| Announcement Date | 3/12/20 | 3/22/21 | 3/18/22 | 3/13/23 | 3/13/24 | - | - | - |
1TWD in Million2TWD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 36,534 | 39,666 | 47,333 | 56,017 | 59,194 | 71,501 | 94,403 | 110,867 |
| EBITDA 1 | - | 4,496 | 6,404 | 8,021 | 9,375 | 13,035 | 19,413 | 23,612 |
| EBIT 1 | 1,259 | 3,260 | 4,827 | 6,306 | 7,421 | 10,852 | 16,669 | 20,816 |
| Operating Margin | 3.45% | 8.22% | 10.2% | 11.26% | 12.54% | 15.18% | 17.66% | 18.78% |
| Earnings before Tax (EBT) 1 | - | - | - | - | 8,025 | 11,470 | 15,762 | 18,014 |
| Net income 1 | - | - | - | - | 5,305 | 7,467 | 10,677 | 12,509 |
| Net margin | - | - | - | - | 8.96% | 10.44% | 11.31% | 11.28% |
| EPS 2 | - | - | - | - | 14.11 | 19.48 | 27.86 | 32.63 |
| Free Cash Flow 1 | - | 2,462 | 1,301 | 5,204 | 6,667 | 7,285 | 11,155 | 11,812 |
| FCF margin | - | 6.21% | 2.75% | 9.29% | 11.26% | 10.19% | 11.82% | 10.65% |
| FCF Conversion (EBITDA) | - | 54.76% | 20.32% | 64.88% | 71.11% | 55.88% | 57.46% | 50.02% |
| FCF Conversion (Net income) | - | - | - | - | 125.68% | 97.56% | 104.48% | 94.42% |
| Dividend per Share 2 | - | 2.800 | 3.300 | 4.520 | 7.000 | 8.924 | 13.09 | 15.96 |
| Announcement Date | 3/12/20 | 3/22/21 | 3/18/22 | 3/13/23 | 3/13/24 | - | - | - |
1TWD in Million2TWD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 12,593 | 13,764 | 14,883 | 14,777 | 11,835 | 14,871 | 15,769 | 16,720 | 15,309 | 16,075 | 18,648 | 21,387 | 20,579 | 21,645 |
| EBITDA 1 | - | - | - | - | - | - | - | 2,949 | 2,492 | 3,182 | 3,809 | 4,507 | - | - |
| EBIT 1 | 1,336 | 1,528 | 1,756 | 1,686 | 1,352 | 1,547 | 2,105 | 2,416 | 1,935 | 2,349 | 2,957 | 3,703 | 3,436 | 3,846 |
| Operating Margin | 10.61% | 11.1% | 11.8% | 11.41% | 11.43% | 10.41% | 13.35% | 14.45% | 12.64% | 14.61% | 15.86% | 17.31% | 16.7% | 17.77% |
| Earnings before Tax (EBT) 1 | - | - | - | - | - | - | 2,220 | 2,491 | 2,330 | 2,374 | 2,925 | 3,567 | 3,056 | 3,516 |
| Net income 1 | - | - | - | - | - | - | 1,426 | 1,671 | 1,564 | 1,540 | 1,923 | 2,371 | 2,066 | 2,406 |
| Net margin | - | - | - | - | - | - | 9.04% | 9.99% | 10.22% | 9.58% | 10.31% | 11.09% | 10.04% | 11.12% |
| EPS 2 | - | - | - | - | - | - | 3.720 | 4.360 | 4.080 | 4.082 | 5.096 | 6.222 | 5.631 | 6.632 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 5/11/22 | 8/9/22 | 11/11/22 | 3/13/23 | 5/10/23 | 8/9/23 | 11/10/23 | 3/13/24 | 5/10/24 | - | - | - | - | - |
1TWD in Million2TWD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - | - | - |
| Net Cash position 1 | - | 4,358 | 4,185 | 8,757 | 13,997 | 19,245 | 27,154 | 34,214 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Free Cash Flow 1 | - | 2,462 | 1,301 | 5,204 | 6,667 | 7,285 | 11,155 | 11,812 |
| ROE (net income / shareholders' equity) | - | 19.6% | 25.2% | 29.8% | 28.3% | 28.8% | 34.1% | 32.9% |
| ROA (Net income/ Total Assets) | - | 5.03% | - | - | 8.03% | 10.3% | 13.7% | 13.8% |
| Assets 1 | - | - | - | - | 66,070 | 72,286 | 78,082 | 90,789 |
| Book Value Per Share 2 | - | 29.90 | 35.10 | 43.90 | 57.50 | 72.80 | 91.60 | 115.0 |
| Cash Flow per Share 2 | - | - | - | - | 26.70 | 26.30 | 38.00 | 62.10 |
| Capex 1 | - | 2,407 | 1,540 | 3,636 | 3,657 | 3,342 | 3,214 | 3,500 |
| Capex / Sales | - | 6.07% | 3.25% | 6.49% | 6.18% | 4.67% | 3.4% | 3.16% |
| Announcement Date | 3/12/20 | 3/22/21 | 3/18/22 | 3/13/23 | 3/13/24 | - | - | - |
1TWD in Million2TWD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
D
Sell
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
620
TWD
Average target price
835.9
TWD
Spread / Average Target
+34.82%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +84.25% | 7.34B | |
| +73.14% | 94.1B | |
| +20.24% | 35.4B | |
| +21.26% | 26.76B | |
| +16.57% | 20.9B | |
| -0.55% | 16.89B | |
| +13.69% | 15.52B | |
| -1.12% | 11.1B | |
| +21.37% | 11.15B | |
| +11.05% | 9.71B |
- Stock Market
- Equities
- 3017 Stock
- Financials Asia Vital Components Co., Ltd.
